project id: TCGA-BLCA; case submitter id: TCGA-FD-A3SJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 8.7; age at index: 59; days to birth: -21615; days to death: 739; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1951; year of death: 2012; age at diagnosis: 21615; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 785; days to sample procurement: 0; initial weight: 670.0; portion submitter id: TCGA-FD-A3SJ-01A-12; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 70.0; percent tumor nuclei: 75.0;